Dihexa is integrated into a personalized protocol based on your root cause and goals
It names women with normal metabolic status, eating disorders, or severe gastrointestinal symptoms as potentially unsuitable, in contrast to those with documented metabolic dysfunction, insulin resistance, or overweight and obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Novoselov SV, Rao M, Onoshko NV, Zhi H, Kryukov GV, Xiang Y, Weeks DP, Hatfield DL, Gladyshev VN
This peptide is bioidentical to endogenous gonadotropin hormone-releasing hormone, and used for diagnostic purposes to evaluate the functional integrity of the hypothalamicpituitarygonadal (HPG) axis
S., Lefkowitz, R
Epidemiological data in diabetic populations indicate that people taking GLP-1RAs were about 40% less likely to develop DLB, as compared with those not taking them (138)